The FDA today approved a new weight-loss drug for people who are obese or overweight with at least one weight-related health condition, easing a burden that San Diego’s Orexigen Therapeutics (NASDAQ: OREX) has been carrying for a long time.
via Get Fit Bookmark http://ift.tt/1qunw7F
via Tumblr http://ift.tt/1m1PxlR
No comments:
Post a Comment